Remarks
Europe’s Latest Vaccine Controversy Risks Being a Crisis Too Far
EU members’ decision to suspend AstraZeneca shots threatens to deepen the bloc's internal and external tensions.
This article is for subscribers only.
The European Union prides itself on its habit of emerging stronger from crises. Its chaotic vaccine rollout may prove the exception to the rule.
The move by several countries to suspend AstraZeneca Plc’s Covid vaccine over concerns about its safety — against the advice of the bloc’s regulator — is exposing flaws in the communal system that threaten to weaken the EU politically and economically.